VIVOS THERAPEUTICS - AUDIT REPORTS FOR FY2025 AND FY2024 INCLUDE SUBSTANTIAL DOUBT ABOUT GOING CONCERN - SEC FILING

Reuters · 1d ago

Please log in to view news